ArticleInternational journal of molecular sciences2023

Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy.

Cezary Tręda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.